nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxcarbazepine—Ear infection—Octreotide—thymus cancer	0.0306	0.0306	CcSEcCtD
Oxcarbazepine—Ulcerative stomatitis—Octreotide—thymus cancer	0.0282	0.0282	CcSEcCtD
Oxcarbazepine—Renal pain—Octreotide—thymus cancer	0.0248	0.0248	CcSEcCtD
Oxcarbazepine—Multiple fractures—Octreotide—thymus cancer	0.0224	0.0224	CcSEcCtD
Oxcarbazepine—Fracture—Octreotide—thymus cancer	0.0224	0.0224	CcSEcCtD
Oxcarbazepine—Haemorrhoids—Octreotide—thymus cancer	0.0221	0.0221	CcSEcCtD
Oxcarbazepine—Transaminases increased—Octreotide—thymus cancer	0.0214	0.0214	CcSEcCtD
Oxcarbazepine—Cholelithiasis—Octreotide—thymus cancer	0.0209	0.0209	CcSEcCtD
Oxcarbazepine—Hypothyroidism—Octreotide—thymus cancer	0.0203	0.0203	CcSEcCtD
Oxcarbazepine—Neuralgia—Octreotide—thymus cancer	0.0187	0.0187	CcSEcCtD
Oxcarbazepine—Metrorrhagia—Octreotide—thymus cancer	0.0182	0.0182	CcSEcCtD
Oxcarbazepine—Nephrolithiasis—Octreotide—thymus cancer	0.0162	0.0162	CcSEcCtD
Oxcarbazepine—Acne—Octreotide—thymus cancer	0.0155	0.0155	CcSEcCtD
Oxcarbazepine—Contusion—Octreotide—thymus cancer	0.0149	0.0149	CcSEcCtD
Oxcarbazepine—Viral infection—Octreotide—thymus cancer	0.0144	0.0144	CcSEcCtD
Oxcarbazepine—Rectal haemorrhage—Octreotide—thymus cancer	0.0144	0.0144	CcSEcCtD
Oxcarbazepine—Vaginal inflammation—Octreotide—thymus cancer	0.013	0.013	CcSEcCtD
Oxcarbazepine—Eructation—Octreotide—thymus cancer	0.0128	0.0128	CcSEcCtD
Oxcarbazepine—Vaginal infection—Octreotide—thymus cancer	0.0123	0.0123	CcSEcCtD
Oxcarbazepine—Mouth ulceration—Octreotide—thymus cancer	0.0118	0.0118	CcSEcCtD
Oxcarbazepine—Urine output increased—Octreotide—thymus cancer	0.0118	0.0118	CcSEcCtD
Oxcarbazepine—Hyperkinesia—Octreotide—thymus cancer	0.0114	0.0114	CcSEcCtD
Oxcarbazepine—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.0109	0.0109	CcSEcCtD
Oxcarbazepine—Polyuria—Octreotide—thymus cancer	0.0108	0.0108	CcSEcCtD
Oxcarbazepine—Hot flush—Octreotide—thymus cancer	0.0101	0.0101	CcSEcCtD
Oxcarbazepine—Amnesia—Octreotide—thymus cancer	0.0101	0.0101	CcSEcCtD
Oxcarbazepine—Menopausal symptoms—Octreotide—thymus cancer	0.01	0.01	CcSEcCtD
Oxcarbazepine—Visual disturbance—Octreotide—thymus cancer	0.00998	0.00998	CcSEcCtD
Oxcarbazepine—Hypoglycaemia—Octreotide—thymus cancer	0.00969	0.00969	CcSEcCtD
Oxcarbazepine—Pain in extremity—Octreotide—thymus cancer	0.00945	0.00945	CcSEcCtD
Oxcarbazepine—Psychotic disorder—Octreotide—thymus cancer	0.00923	0.00923	CcSEcCtD
Oxcarbazepine—Irritability—Octreotide—thymus cancer	0.00902	0.00902	CcSEcCtD
Oxcarbazepine—Abdominal pain upper—Octreotide—thymus cancer	0.00863	0.00863	CcSEcCtD
Oxcarbazepine—Nasopharyngitis—Octreotide—thymus cancer	0.00845	0.00845	CcSEcCtD
Oxcarbazepine—Gastritis—Octreotide—thymus cancer	0.00837	0.00837	CcSEcCtD
Oxcarbazepine—Muscular weakness—Octreotide—thymus cancer	0.00834	0.00834	CcSEcCtD
Oxcarbazepine—Asthma—Octreotide—thymus cancer	0.00817	0.00817	CcSEcCtD
Oxcarbazepine—Bronchospasm—Octreotide—thymus cancer	0.00804	0.00804	CcSEcCtD
Oxcarbazepine—Pancreatitis—Octreotide—thymus cancer	0.00801	0.00801	CcSEcCtD
Oxcarbazepine—Sweating increased—Octreotide—thymus cancer	0.00796	0.00796	CcSEcCtD
Oxcarbazepine—Bronchitis—Octreotide—thymus cancer	0.00786	0.00786	CcSEcCtD
Oxcarbazepine—Dysuria—Octreotide—thymus cancer	0.00764	0.00764	CcSEcCtD
Oxcarbazepine—Upper respiratory tract infection—Octreotide—thymus cancer	0.00759	0.00759	CcSEcCtD
Oxcarbazepine—Pollakiuria—Octreotide—thymus cancer	0.00755	0.00755	CcSEcCtD
Oxcarbazepine—Weight increased—Octreotide—thymus cancer	0.00744	0.00744	CcSEcCtD
Oxcarbazepine—Weight decreased—Octreotide—thymus cancer	0.00739	0.00739	CcSEcCtD
Oxcarbazepine—Hyperglycaemia—Octreotide—thymus cancer	0.00737	0.00737	CcSEcCtD
Oxcarbazepine—Pneumonia—Octreotide—thymus cancer	0.00733	0.00733	CcSEcCtD
Oxcarbazepine—Urinary tract infection—Octreotide—thymus cancer	0.00708	0.00708	CcSEcCtD
Oxcarbazepine—Haematuria—Octreotide—thymus cancer	0.00695	0.00695	CcSEcCtD
Oxcarbazepine—Hepatobiliary disease—Octreotide—thymus cancer	0.00689	0.00689	CcSEcCtD
Oxcarbazepine—Epistaxis—Octreotide—thymus cancer	0.00687	0.00687	CcSEcCtD
Oxcarbazepine—Sinusitis—Octreotide—thymus cancer	0.00683	0.00683	CcSEcCtD
Oxcarbazepine—Bradycardia—Octreotide—thymus cancer	0.00666	0.00666	CcSEcCtD
Oxcarbazepine—Rhinitis—Octreotide—thymus cancer	0.00656	0.00656	CcSEcCtD
Oxcarbazepine—Hepatitis—Octreotide—thymus cancer	0.00654	0.00654	CcSEcCtD
Oxcarbazepine—Hypoaesthesia—Octreotide—thymus cancer	0.00651	0.00651	CcSEcCtD
Oxcarbazepine—Pharyngitis—Octreotide—thymus cancer	0.00649	0.00649	CcSEcCtD
Oxcarbazepine—Oedema peripheral—Octreotide—thymus cancer	0.00644	0.00644	CcSEcCtD
Oxcarbazepine—Visual impairment—Octreotide—thymus cancer	0.0063	0.0063	CcSEcCtD
Oxcarbazepine—Tinnitus—Octreotide—thymus cancer	0.0061	0.0061	CcSEcCtD
Oxcarbazepine—Flushing—Octreotide—thymus cancer	0.00607	0.00607	CcSEcCtD
Oxcarbazepine—Cardiac disorder—Octreotide—thymus cancer	0.00607	0.00607	CcSEcCtD
Oxcarbazepine—Immune system disorder—Octreotide—thymus cancer	0.00591	0.00591	CcSEcCtD
Oxcarbazepine—Arrhythmia—Octreotide—thymus cancer	0.00584	0.00584	CcSEcCtD
Oxcarbazepine—Alopecia—Octreotide—thymus cancer	0.00578	0.00578	CcSEcCtD
Oxcarbazepine—Mental disorder—Octreotide—thymus cancer	0.00573	0.00573	CcSEcCtD
Oxcarbazepine—Malnutrition—Octreotide—thymus cancer	0.00569	0.00569	CcSEcCtD
Oxcarbazepine—Flatulence—Octreotide—thymus cancer	0.00561	0.00561	CcSEcCtD
Oxcarbazepine—Tension—Octreotide—thymus cancer	0.00559	0.00559	CcSEcCtD
Oxcarbazepine—Nervousness—Octreotide—thymus cancer	0.00553	0.00553	CcSEcCtD
Oxcarbazepine—Back pain—Octreotide—thymus cancer	0.00551	0.00551	CcSEcCtD
Oxcarbazepine—Vision blurred—Octreotide—thymus cancer	0.00537	0.00537	CcSEcCtD
Oxcarbazepine—Tremor—Octreotide—thymus cancer	0.00533	0.00533	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Octreotide—thymus cancer	0.00528	0.00528	CcSEcCtD
Oxcarbazepine—Agitation—Octreotide—thymus cancer	0.00523	0.00523	CcSEcCtD
Oxcarbazepine—Malaise—Octreotide—thymus cancer	0.00513	0.00513	CcSEcCtD
Oxcarbazepine—Vertigo—Octreotide—thymus cancer	0.00512	0.00512	CcSEcCtD
Oxcarbazepine—Syncope—Octreotide—thymus cancer	0.00511	0.00511	CcSEcCtD
Oxcarbazepine—Palpitations—Octreotide—thymus cancer	0.00503	0.00503	CcSEcCtD
Oxcarbazepine—Loss of consciousness—Octreotide—thymus cancer	0.005	0.005	CcSEcCtD
Oxcarbazepine—Cough—Octreotide—thymus cancer	0.00497	0.00497	CcSEcCtD
Oxcarbazepine—Convulsion—Octreotide—thymus cancer	0.00493	0.00493	CcSEcCtD
Oxcarbazepine—Hypertension—Octreotide—thymus cancer	0.00492	0.00492	CcSEcCtD
Oxcarbazepine—Chest pain—Octreotide—thymus cancer	0.00485	0.00485	CcSEcCtD
Oxcarbazepine—Myalgia—Octreotide—thymus cancer	0.00485	0.00485	CcSEcCtD
Oxcarbazepine—Arthralgia—Octreotide—thymus cancer	0.00485	0.00485	CcSEcCtD
Oxcarbazepine—Anxiety—Octreotide—thymus cancer	0.00483	0.00483	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00481	0.00481	CcSEcCtD
Oxcarbazepine—Discomfort—Octreotide—thymus cancer	0.00479	0.00479	CcSEcCtD
Oxcarbazepine—Dry mouth—Octreotide—thymus cancer	0.00474	0.00474	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Octreotide—thymus cancer	0.00465	0.00465	CcSEcCtD
Oxcarbazepine—Infection—Octreotide—thymus cancer	0.00462	0.00462	CcSEcCtD
Oxcarbazepine—Shock—Octreotide—thymus cancer	0.00457	0.00457	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Octreotide—thymus cancer	0.00456	0.00456	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Octreotide—thymus cancer	0.00455	0.00455	CcSEcCtD
Oxcarbazepine—Tachycardia—Octreotide—thymus cancer	0.00453	0.00453	CcSEcCtD
Oxcarbazepine—Skin disorder—Octreotide—thymus cancer	0.00451	0.00451	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Octreotide—thymus cancer	0.00449	0.00449	CcSEcCtD
Oxcarbazepine—Anorexia—Octreotide—thymus cancer	0.00443	0.00443	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00423	0.00423	CcSEcCtD
Oxcarbazepine—Insomnia—Octreotide—thymus cancer	0.0042	0.0042	CcSEcCtD
Oxcarbazepine—Dyspnoea—Octreotide—thymus cancer	0.00414	0.00414	CcSEcCtD
Oxcarbazepine—Somnolence—Octreotide—thymus cancer	0.00413	0.00413	CcSEcCtD
Oxcarbazepine—Dyspepsia—Octreotide—thymus cancer	0.00409	0.00409	CcSEcCtD
Oxcarbazepine—Decreased appetite—Octreotide—thymus cancer	0.00404	0.00404	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Octreotide—thymus cancer	0.00401	0.00401	CcSEcCtD
Oxcarbazepine—Fatigue—Octreotide—thymus cancer	0.00401	0.00401	CcSEcCtD
Oxcarbazepine—Pain—Octreotide—thymus cancer	0.00397	0.00397	CcSEcCtD
Oxcarbazepine—Constipation—Octreotide—thymus cancer	0.00397	0.00397	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Octreotide—thymus cancer	0.00383	0.00383	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Octreotide—thymus cancer	0.0038	0.0038	CcSEcCtD
Oxcarbazepine—Urticaria—Octreotide—thymus cancer	0.00369	0.00369	CcSEcCtD
Oxcarbazepine—Abdominal pain—Octreotide—thymus cancer	0.00367	0.00367	CcSEcCtD
Oxcarbazepine—Body temperature increased—Octreotide—thymus cancer	0.00367	0.00367	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Octreotide—thymus cancer	0.00342	0.00342	CcSEcCtD
Oxcarbazepine—Asthenia—Octreotide—thymus cancer	0.00333	0.00333	CcSEcCtD
Oxcarbazepine—Pruritus—Octreotide—thymus cancer	0.00329	0.00329	CcSEcCtD
Oxcarbazepine—Diarrhoea—Octreotide—thymus cancer	0.00318	0.00318	CcSEcCtD
Oxcarbazepine—Dizziness—Octreotide—thymus cancer	0.00307	0.00307	CcSEcCtD
Oxcarbazepine—Vomiting—Octreotide—thymus cancer	0.00295	0.00295	CcSEcCtD
Oxcarbazepine—Rash—Octreotide—thymus cancer	0.00293	0.00293	CcSEcCtD
Oxcarbazepine—Dermatitis—Octreotide—thymus cancer	0.00293	0.00293	CcSEcCtD
Oxcarbazepine—Headache—Octreotide—thymus cancer	0.00291	0.00291	CcSEcCtD
Oxcarbazepine—Nausea—Octreotide—thymus cancer	0.00276	0.00276	CcSEcCtD
